Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 48 holding rows worth $189,197,000.

Accession
0001633055-19-000001
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 48 entries on the cover page, a total value of $189,197,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $189,197,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALLERGAN PLCG0177J108SHS119,071$15,915,000thousands by filing date
Cigna Corporation125523100COM70,944$13,474,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock123,905$12,851,000thousands by filing date
CELGENE CORP151020104COM168,609$10,806,000thousands by filing date
CVS Health Corporation126650100COM147,629$9,673,000thousands by filing date
Medtronic PlcG5960L103COM92,827$8,444,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO46,100$8,023,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS282,108$7,679,000thousands by filing date
DAVITA INC COM23918K108Stock140,729$7,242,000thousands by filing date
R1 RCM INC749397105COM893,421$7,103,000thousands by filing date
INTRICON CORP46121H109COM247,980$6,542,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS461,234$5,895,000thousands by filing date
VERADIGM INC01988P108COMMON STOCK591,533$5,702,000thousands by filing date
HOLOGIC INC436440101COM135,805$5,582,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock41,132$5,315,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock85,272$5,261,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM118,424$4,407,000thousands by filing date
UnitedHealth Group Inc91324P102COM16,732$4,168,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR81,401$3,534,000thousands by filing date
INSULET CORP COM45784P101Stock40,727$3,230,000thousands by filing date
BAUSCH HEALTH COS INC COM071734107Stock163,908$3,027,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM318,185$2,816,000thousands by filing date
Bristol-Myers Squibb Company110122108COM49,337$2,565,000thousands by filing date
STANDARD BIOTOOLS INC34385PAA6NOTE 2.750% 2/02,750,000$2,517,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM21,615$2,359,000thousands by filing date
NEVRO CORP64157F103COM54,977$2,138,000thousands by filing date
MYLAN NVN59465109SHS EURO77,135$2,113,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM236,648$2,040,000thousands by filing date
RVL PHARMACEUTICALS PLCG6S41R101COM232,048$1,798,000thousands by filing date
PETMED EXPRESS INC716382106COM67,010$1,559,000thousands by filing date
ACCURAY INC DEL004397105COM455,018$1,552,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock102,345$1,458,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock18,018$1,252,000thousands by filing date
Stryker Corporation863667101COM7,319$1,147,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR73,884$1,139,000thousands by filing date
Boston Scientific Corporation101137107COM30,560$1,080,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM232,727$926,000thousands by filing date
Johnson & Johnson478160104COM6,588$850,000thousands by filing date
LIQUIDIA CORPORATION COM NEW53635D202Stock39,139$848,000thousands by filing date
AXOGEN INC05463X106COM39,961$816,000thousands by filing date
ANAPTYSBIO INC032724106COM12,734$812,000thousands by filing date
CENCORA INC COM03073E105Stock8,340$620,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock209,195$590,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM58,240$558,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM66,639$553,000thousands by filing date
MCKESSON CORP COM58155Q103Stock4,966$549,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM53,466$409,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock12,500$260,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-19-000001this filing2019-02-14acceptance time not in the bulk data set